-
Product Insights
Innovations in Neuro Microcatheters – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Neuro Microcatheters - Global Pipeline Summary" provides comprehensive information about the Neuro Microcatheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Neuro Microcatheters report provides key information and data related to: Extensive coverage of the Neuro Microcatheters under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories,...
-
Product Insights
NewClearPoint Neuro Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our ClearPoint Neuro Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. ClearPoint Neuro Inc (ClearPoint) is a clinical gear organization. It creates and commercializes stages for carrying out intrusive surgeries. Its items incorporate ClearPoint framework a careful stage, that empowers conveyance of treatments treat a neurological infections and issues by giving continuous X-ray direction; SmartFlow Neuro Ventricular Cannula a X-ray Directed Medication Conveyance framework and TRANBERG Warm Treatment Framework. These...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lumateperone Tosylate in Schizoaffective Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lumateperone Tosylate in Schizoaffective Disorder report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lumateperone Tosylate in Schizoaffective Disorder Drug Details: Lumateperone tosylate (Caplyta)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lumateperone Tosylate in Major Depressive Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lumateperone Tosylate in Major Depressive Disorder report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lumateperone Tosylate in Major Depressive Disorder Drug Details: Lumateperone...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lumateperone Tosylate in Bipolar II Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lumateperone Tosylate in Bipolar II Disorder report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lumateperone Tosylate in Bipolar II Disorder Drug Details: Lumateperone...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lumateperone Tosylate in Bipolar I Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lumateperone Tosylate in Bipolar I Disorder report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lumateperone Tosylate in Bipolar I Disorder Drug Details: Lumateperone...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Azetukalner in Major Depressive Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Azetukalner in Major Depressive Disorder report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Azetukalner in Major Depressive Disorder Drug Details: Azetukalner (XEN-1101, 1OP-2198)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST101 in Sarcomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST101 in Sarcomas report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST101 in Sarcomas Drug Details: ST-101 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST101 in Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST101 in Glioblastoma Multiforme (GBM) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST101 in Glioblastoma Multiforme (GBM) Drug Details: ST-101 is under...